Bellevue Group AG Q4 2018 Filing

Filed February 12, 2019

Portfolio Value

$1.5T

Holdings

138

Report Date

Q4 2018

Filing Type

13F-HR

All Holdings (138 positions)

#StockSharesValue% PortfolioType
101
ACADACADIA PHARMACEUTICALS INC
95,800$1.5B0.10%
102
ANGOANGIODYNAMICS INC
75,700$1.5B0.10%
103
FGENEURFIBROGEN INC
32,000$1.5B0.10%
104
PODDINSULET CORP
18,000$1.4B0.09%
105
SRPTSAREPTA THERAPEUTICS INC
12,700$1.4B0.09%
106
VCRAUSDVOCERA COMMUNICATONS INC
32,950$1.3B0.09%
107
AMRXAMNEAL PHARMACEUTICALS INC
95,000$1.3B0.08%
108
BLUEBIRD BIO INC
12,900$1.3B0.08%
109
ENDO INTL PLC
170,392$1.2B0.08%
110
ARGXARGENX SE
12,600$1.2B0.08%
111
LOXO ONCOLOGY INC
8,600$1.2B0.08%
112
ARNAEURARENA PHARMACEUTICALS INC
30,317$1.2B0.08%
113
MRKMERCK & CO INC
15,000$1.1B0.08%
114
MRTXEURMIRATI THERAPEUTICS INC
24,000$1.0B0.07%
115
SG7SAGE THERAPEUTICS INC
10,600$1.0B0.07%
116
RGNXREGENXBIO INC
23,300$977.0M0.06%
117
RAREULTRAGENYX PHARMACEUTICAL INC
22,200$965.0M0.06%
118
MYGNMYRIAD GENETICS INC
31,900$927.0M0.06%
119
TEVATEVA PHARMACEUTICAL INDS LTD
60,000$925.0M0.06%
120
EVHEVOLENT HEALTH INC
45,270$903.0M0.06%
121
LABORATORY CORP AMER HLDGS
6,500$821.0M0.05%
122
IRWDIRONWOOD PHARMACEUTICALS INC
76,500$793.0M0.05%
123
CLLSCELLECTIS S A
46,750$778.0M0.05%
124
MCKMCKESSON CORP
6,879$760.0M0.05%
125
ADAPYADAPTIMMUNE THERAPEUTICS PLC
131,135$754.0M0.05%
126
PTCTPTC THERAPEUTICS INC
21,700$745.0M0.05%
127
GW PHARMACEUTICALS PLC
6,429$626.0M0.04%
128
XLRNACCELERON PHARMA INC
14,300$623.0M0.04%
129
HCSGHEALTHCARE SVCS GRP INC
15,000$603.0M0.04%
130
ITCIEURINTRA CELLULAR THERAPIES INC
52,600$599.0M0.04%
131
AFFIMED N V
170,000$529.0M0.03%
132
PORTOLA PHARMACEUTICALS INC
25,650$501.0M0.03%
133
PINCPREMIER INC
13,400$500.0M0.03%
134
VAREURVARIAN MED SYS INC
3,122$354.0M0.02%
135
QUREUNIQURE NV
10,000$288.0M0.02%
136
VYGRVOYAGER THERAPEUTICS INC
27,900$262.0M0.02%
137
NTLAINTELLIA THERAPEUTICS INC
15,834$216.0M0.01%
138
IOVAIOVANCE BIOTHERAPEUTICS INC
16,000$142.0M0.01%
PreviousPage 2 of 2